Mutual of America Capital Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Mutual of America Capital Management’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-9,784	Closed	-$600K	–	1276
2013 Q3	$600K	Buy	9,784 +247	+3%	+$16.7K	0.02%	1055
2013 Q2	$558K	Buy	+9,537	New	+$587K	0.02%	1044

Other funds holding OREX

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mutual of America Capital Management's OREX Position: Q4 2013 in Review

Mutual of America Capital Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q4 2013, closing a stake of 9,784 shares — an estimated $600K sold.

Mutual of America Capital Management first reported a position in OREX in Q2 2013 and held it in 2 quarters. The position peaked at $600K in Q3 2013. 124 funds tracked by Wall St. Rank hold OREX as of Q4 2013.

Mutual of America Capital Management reported no remaining Orexigen Therapeutics, Inc. position as of Q4 2013 after selling out during the quarter.
Mutual of America Capital Management sold 9,784 Orexigen Therapeutics, Inc. shares in Q4 2013, an estimated $600K.
Mutual of America Capital Management first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 2 quarters.
Mutual of America Capital Management's Orexigen Therapeutics, Inc. position peaked at $600K in Q3 2013.
124 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q4 2013.

Based on Mutual of America Capital Management's 13F filing for Q4 2013, filed 5 Feb 2014.